Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an Immune-Related Prognostic Signature in Breast Cancer

28 Jan 2020

Abstract excerpt

Background: Although increased early detection, diagnosis and treatment have improved the outcome of breast cancer patients, prognosis estimation still poses challenges due to the disease heterogeneity. Accumulating data indicated an evident correlation between tumor immune microenvironment and clinical outcomes. Objective: To construct an immune-related signature that can estimate disease prognosis and patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32047513
DOI: 10.3389/fgene.2019.01390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an Immune-Related Prognostic Signature in Breast CancerPMID 32047513Read ↗

Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerSemantic proximity Read ↗

Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.Semantic proximity Read ↗

Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signatureSemantic proximity Read ↗

Identification of an independent immune-genes prognostic index for breast cancerSemantic proximity Read ↗

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerSemantic proximity Read ↗

A novel 12-gene prognostic signature in breast cancer based on the tumor microenvironmentSemantic proximity Read ↗

Identification and development of an independent immune-related genes prognostic model for breast cancerSemantic proximity Read ↗

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast CancerSemantic proximity Read ↗

Exploration the Significance of a Novel Immune-Related Gene Signature in Prognosis and Immune Microenvironment of Breast CancerSemantic proximity Read ↗

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.Semantic proximity Read ↗

Inflammatory-related Genes Predicts Prognosis in Breast CancerSemantic proximity Read ↗

Identification of an Independent Immune-Genes Prognostic Index for Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.